CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 4 Open-market sale Chief R&D Officer sold 10,484 shares at $3.00 ($31,452)
- 4 Open-market sale Chief Legal Officer sold 8,275 shares at $3.00 ($24,825)
- 4 Open-market sale Chief Financial Officer sold 10,267 shares at $3.00 ($30,801)
- 4 Open-market sale President & CEO sold 19,635 shares at $3.00 ($58,905)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Bylaws or fiscal year change
- 4 Open-market sale Chief R&D Officer sold 13,460 shares at $3.57 ($48,052)
- 4 Open-market sale Chief Legal Officer sold 8,690 shares at $3.57 ($31,023)
- 4 Open-market sale Chief Financial Officer sold 11,095 shares at $3.57 ($39,609)
- 4 Open-market sale President & CEO sold 38,014 shares at $3.57 ($135,710)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
Page 16 of 100 · 1,982 filings